Experts' corner

Leading international Hypoglossal Nerve Stimulation experts share their perspective on OSA, the promising future of HGNS and the Genio® system.

Responsive

Dr. Richard Lewis

ENT Surgeon, Perth, Australia

Dr. Lewis is a true Genio® pioneer, he has performed the first Genio® implantation in the world, has done more than 25 implants and has proctored around 25 surgical procedures of the system worldwide.

Watch his video for an excellent overview of the Genio® system and to hear about the positive impact the therapy has on the quality of life of his patients.

Prof. Dr. Olivier Vanderveken, MD, PhD

Head of Dept. of Otorhinolaryngology Head and Neck surgery, Antwerp University Hospital (UZA), Belgium

Watch the video interview of Prof. Vanderveken to learn more about the history and position of UZA as a center of excellence for the treatment of Obstructive Sleep Apnea(OSA) in Belgium and the potential of hypoglossal nerve stimulation to become a first-line therapy for OSA patients in the future.

Responsive
Responsive

Prof. Dr. med. Clemens Heiser

Head of the Sleep Laboratory at Klinikum rechts der Isar, Technical University of Munich, Germany

Watch the video to find out what Prof. Heiser thinks is in store for the future of hypoglossal nerve stimulation and his experience with Nyxoah’s Genio® therapy.

Questions?
Visit the FAQ

Frequently asked questions
about the Genio® system

FAQ

All rights reserved © 2020 Nyxoah S.A. All content on this presentation, including the texts, trademarks, service marks, logos, illustrations, photos, graphics, design etc., are the property of Nyxoah SA. Nyxoah S.A. owns all rights with respect to any of their trademarks, service marks, logos, and copyrighted works appearing on this presentation. Patented and design protected technology. Device not for sale in U.S. The Genio® system by Nyxoah is intended to be used for patients who suffer from moderate to severe Obstructive Sleep Apnea (AHI of 15 to 65), have not tolerated, failed or refused PAP therapy and are not significantly overweight. Reviewed and approved: February 2020

bubble
bubble
bubble
bubble
bubble